Protocol summary

Study aim
The comparison of anti-pneumococcal antibody titer in pneumococcal conjugate 13 valent with polysaccharide 23 valent vaccination versus pneumococcal polysaccharide 23 valent vaccination alone in hemodialysis patients
Design
All patients who have been started hemodialysis at least 3 months and dialysed at least three times a week. In this study, randomized allocation of hemodialysis patients to two groups of conjugate 13 valent with polysaccharide 23 valent vaccination and polysaccharide 23 valent vaccination alone using Balanced Block randomization technique
Settings and conduct
Hemodialysis patients referring to Loghman Hospital Dialysis Center and Dr. Zahed Dialysis Center
Participants/Inclusion and exclusion criteria
All patients at least 16 years of age who have been started hemodialysis at least 3 months and dialysed at least three times a week. Patients will be excluded from the study if they have one of the following conditions: • immunocompromised • use immunosuppresive agents • Spleen function impairment • HIV infection • Malignancies • (bone marrow transplantation) • history of previous injection of pneumococcal vaccine
Intervention groups
This study is an experimental study in which the effect of antipneumococcal vaccine as an independent variable on the anti-pneumococcal antibody titers in the two groups of conjugate 13 valent with polysaccharide 23 valent vaccination and polysaccharide 23 valent vaccination alone of hemodialysis patients as a dependent variable will be investigated.
Main outcome variables
albumin level; KT / V calculation; serum hematocrit; anti-pneumococcal antibody titer

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20171224038046N1
Registration date: 2018-04-05, 1397/01/16
Registration timing: retrospective

Last update: 2018-04-05, 1397/01/16
Update count: 0
Registration date
2018-04-05, 1397/01/16
Registrant information
Name
Sasan Tavana
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8825 6512
Email address
sasan.tavana2@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2017-06-22, 1396/04/01
Expected recruitment end date
2018-02-19, 1396/11/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The comparison of anti-pneumococcal antibody titer in pneumococcal conjugate 13 valent with polysaccharide 23 valent vaccination versus pneumococcal polysaccharide 23 valent vaccination alone in hemodialysis patients
Public title
The Comparison of the efficacy of once injection of pneumococcal vaccination versus two times injection in hemodialysis patients
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
All patients who have been started hemodialysis at least 3 months All patients who have been dialysed at least three times a week All patients who have at least 16 years old
Exclusion criteria:
Immunocompromised use immunosuppresive agents Spleen function impairment HIV infection Malignancies bone marrow transplantation history of previous injection of pneumococcal vaccine
Age
From 16 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Investigator
Sample size
Target sample size: 50
Randomization (investigator's opinion)
Not randomized
Randomization description
Blinding (investigator's opinion)
Single blinded
Blinding description
The main researcher of the project is not informed about the allocation of the groups, so that the vaccines are provided to clinical care and divided into two groups based on the randomization of the participants in the project. Clinical care is aware of the allocation of the groups for following up the side effects. The participants in the plan will be informed which group is located in.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shahid Beheshti University of Medical Sciences
Street address
Shahid Beheshti University of Medical Sciences, koodakyar street, Daneshjoo Blvd.
City
Tehran
Province
Tehran
Postal code
1985717443
Approval date
2017-11-22, 1396/09/01
Ethics committee reference number
IR-SBMU.SMSP.IRC.1396.572

Health conditions studied

1

Description of health condition studied
Pneumonia
ICD-10 code
N18.6
ICD-10 code description
End stage renal disease

Primary outcomes

1

Description
anti-pneumococcal antibody titer
Timepoint
1 month and 6 months after vaccination
Method of measurement
Human Anti-S. Pneumococcal vaccine (Pneumovax/CPS23) IgG ELISA Kit; (23 serotypes: 1, 2, 3, 4, 5, 6b, 7F, 8,9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F), quantitative

Secondary outcomes

1

Description
Evaluation of anti-pneumococcal antibody titre constancy
Timepoint
One month and six months after the date of the 23 valent polysaccharide vaccination
Method of measurement
To determine the antibody titer and ELIZA test, The antibody titre will be measured with a specific kit (Copper Serum / Plasma)

Intervention groups

1

Description
Intervention group: 25 patients received 13 valent anti pneumococcal vaccine, after 8 weeks received 23 valent vaccine.
Category
Treatment - Drugs

2

Description
Control group: 25 patients receive 23 valent vaccine.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Loghman hospital
Full name of responsible person
Zahra Ghanbari
Street address
Lashgar intersection, Makhsoos Street, Loghman Hospital
City
Tehran
Province
Tehran
Postal code
1333631151
Phone
+98 21 5541 9423
Email
loghman.hospital@sbmu.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Research deputy of Shahid Beheshti Medical Science
Full name of responsible person
Dr. Seyyed Ali Ziayi
Street address
Shahid Beheshti University of Medical Sciences, koodakyar street, Daneshjoo Blvd.
City
Tehran
Province
Tehran
Postal code
1983969411
Phone
+98 21 2243 1920
Email
pr.office@mail.sbu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Research deputy of Shahid Beheshti Medical Science
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Shima Shahi
Position
resident
Latest degree
Medical doctor
Other areas of specialty/work
Internal Medicine
Street address
Shahid Modarres Hospital, Kaj Sqaure, Sa'adat Aabad St.
City
Tehran
Province
Tehran
Postal code
1998734383
Phone
+98 21 2207 4101
Email
modarres@sbmu.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Shima Shahi
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Internal Medicine
Street address
سعادت آباد میدان کاج بیمارستان شهید مدرس
City
Tehran
Province
Tehran
Postal code
1998734383
Phone
+98 21 2207 4101
Email
modarres@sbmu.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Shima Shahi
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Internal Medicine
Street address
Shahid Modarres Hospital, Kaj Sqaure, Sa'adat Aabad St.
City
Tehran
Province
Tehran
Postal code
1998734383
Phone
+98 21 2207 4101
Email
modarres@sbmu.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...